Nevalainen D E, Lloyd H L
Abbott Quality Institute, Abbott Laboratories, Chicago, Illinois, USA.
Transfusion. 1995 Jun;35(6):521-4. doi: 10.1046/j.1537-2995.1995.35695288774.x.
The recent American Association of Blood Banks publications Quality Program and Quality Systems in the Blood Bank and Laboratory Environment, the FDA's draft guidelines, and recent changes in the GMP regulations all discuss the benefits of implementing quality systems in blood center and/or manufacturing operations. While the medical device GMPs in the United States have been rewritten to accommodate a quality system approach similar to ISO 9000, the Center for Biologics Evaluation and Research of the FDA is also beginning to make moves toward adopting "quality systems audits" as an inspection process rather than using the historical approach of record reviews. The approach is one of prevention of errors rather than detection after the fact (Tourault MA, oral communication, November 1994). The ISO 9000 series of standards is a quality system that has worldwide scope and can be applied in any industry or service. The use of such international standards in blood banking should raise the level of quality within an organization, among organizations on a regional level, within a country, and among nations on a worldwide basis. Whether an organization wishes to become registered to a voluntary standard or not, the use of such standards to become ISO 9000-compliant would be a move in the right direction and would be a positive sign to the regulatory authorities and the public that blood banking is making a visible effort to implement world-class quality systems in its operations. Implementation of quality system standards such as the ISO 9000 series will provide an organized approach for blood banks and blood bank testing operations. With the continued trend toward consolidation and mergers, resulting in larger operational units with more complexity, quality systems will become even more important as the industry moves into the future.(ABSTRACT TRUNCATED AT 250 WORDS)
美国血库协会近期发布的《血库与实验室环境中的质量计划和质量体系》、美国食品药品监督管理局(FDA)的指南草案以及药品生产质量管理规范(GMP)法规的最新变化,均讨论了在血库和/或生产操作中实施质量体系的益处。虽然美国的医疗器械GMP已进行修订,以采用类似于ISO 9000的质量体系方法,但FDA的生物制品评估和研究中心也开始采取行动,采用“质量体系审核”作为检查流程,而非使用以往的记录审查方法。这种方法是预防错误,而非事后检测(图罗特·马,口头交流,1994年11月)。ISO 9000系列标准是一个具有全球范围、可应用于任何行业或服务的质量体系。在血库中使用此类国际标准应能提高组织内部、区域层面各组织之间、一个国家内部以及全球各国之间的质量水平。无论一个组织是否希望注册到自愿性标准,采用此类标准以符合ISO 9000要求都将是朝着正确方向迈出的一步,并且向监管机构和公众表明血库在其运营中为实施世界级质量体系做出了切实努力,这是一个积极的信号。实施诸如ISO 9000系列这样的质量体系标准将为血库和血库检测操作提供一种有组织的方法。随着合并和兼并的持续趋势,形成了更复杂的更大运营单位,随着行业迈向未来,质量体系将变得更加重要。(摘要截取自250字)